Literature DB >> 12093249

Chemoprevention of breast cancer: recommendations and rationale.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12093249     DOI： 10.7326/0003-4819-137-1-200207020-00016

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  19 in total

1.  Nonhormonal management of hot flashes for women on risk reduction therapy.

Authors:  Kostandinos Sideras; Charles L Loprinzi
Journal:  J Natl Compr Canc Netw       Date:  2010-10       Impact factor: 11.908

2.  Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages.

Authors:  Richard L Kravitz; Naihua Duan; Joel Braslow
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

3.  Implementation in a large health system of a program to identify women at high risk for breast cancer.

Authors:  William L Owens; Thomas J Gallagher; Michael J Kincheloe; Victoria L Ruetten
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

4.  "Why take it if you don't have anything?" breast cancer risk perceptions and prevention choices at a public hospital.

Authors:  Talya Salant; Pamela S Ganschow; Olufunmilayo I Olopade; Diane S Lauderdale
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

Review 5.  Breast cancer management: quality-of-life and cost considerations.

Authors:  Davide Radice; Alberto Redaelli
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

6.  Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status.

Authors:  Anika Hüsing; Federico Canzian; Lars Beckmann; Montserrat Garcia-Closas; W Ryan Diver; Michael J Thun; Christine D Berg; Robert N Hoover; Regina G Ziegler; Jonine D Figueroa; Claudine Isaacs; Anja Olsen; Vivian Viallon; Heiner Boeing; Giovanna Masala; Dimitrios Trichopoulos; Petra H M Peeters; Eiliv Lund; Eva Ardanaz; Kay-Tee Khaw; Per Lenner; Laurence N Kolonel; Daniel O Stram; Loïc Le Marchand; Catherine A McCarty; Julie E Buring; I-Min Lee; Shumin Zhang; Sara Lindström; Susan E Hankinson; Elio Riboli; David J Hunter; Brian E Henderson; Stephen J Chanock; Christopher A Haiman; Peter Kraft; Rudolf Kaaks
Journal:  J Med Genet       Date:  2012-09       Impact factor: 6.318

7.  Benign breast disease, mammographic breast density, and the risk of breast cancer.

Authors:  Jeffrey A Tice; Ellen S O'Meara; Donald L Weaver; Celine Vachon; Rachel Ballard-Barbash; Karla Kerlikowske
Journal:  J Natl Cancer Inst       Date:  2013-06-06       Impact factor: 13.506

8.  Mortality from breast carcinoma among US women: the role and implications of socio-economics, heterogeneous insurance, screening mammography, and geography.

Authors:  Albert A Okunade; Mustafa C Karakus
Journal:  Health Care Manag Sci       Date:  2003-11

Review 9.  Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk.

Authors:  Steven R Cummings; Jeffrey A Tice; Scott Bauer; Warren S Browner; Jack Cuzick; Elad Ziv; Victor Vogel; John Shepherd; Celine Vachon; Rebecca Smith-Bindman; Karla Kerlikowske
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

Review 10.  Should tamoxifen be used in breast cancer prevention?

Authors:  Rita Kramer; Powel Brown
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.